NCT01017107View on ClinicalTrials.gov

Activated Protein C in Severe Acute Pancreatitis

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Acute Pancreatitis
Interventions
DRUG

Activated protein C

24 micrograms/kg/hour intravenously for 96 hours

Trial Locations (1)

00290

Helsinki University Central Hospital, Helsinki

All Listed Sponsors
lead

Helsinki University Central Hospital

OTHER

NCT01017107 - Activated Protein C in Severe Acute Pancreatitis | Biotech Hunter | Biotech Hunter